The medicine is highly appreciated by takers for giving no adverse impact on cardiac, digestive and urinary systems and having positive therapeutic effect.

In cooperation with doctors at the Breast Tumor Institute of the Pyongyang Maternity Hospital, the research group has made such achievements as treating tens of breast cancer patients.

Clinical trials have proved that the medicine is also efficacious for gynaecopathy like carcinoma of ovaries and mastopathy.